[1]
|
Parkin, D.M., Pisani, P. and Ferlay, J. (1994) At least one of seven cases of cancer is caused by smoking. Global estimate for 1985. International Journal of Cancer, 59, 494-504. doi:10.1002/ijc.2910590411
|
[2]
|
Pelluchi, C., Bosetti, C., Negri, E., Malvezzi, M. and La Vecchia, C. (2006) Mechanisms of disease: The epidemiology of bladder cancer. Nature Clinical Practice Urology, 3, 327-340. doi:10.1038/ncpuro0510
|
[3]
|
Baris, D. et al. (2009) A case-control study of smoking and bladder cancer risk: Emergent patterns over time. Journal of the National Cancer Institute, 101, 1553-1561.
doi:10.1093/jnci/djp361
|
[4]
|
Boffetta, P. (2008) Tobacco smoking and risk of bladder cancer. Scandinavian Journal of Urology and Nephrology, 42, 45-54. doi:10.1080/03008880802283664
|
[5]
|
Samanic, C., Kogevinas, M., Dosemeci, M., Malats, N., Real, F.X., Garcia-Closas, M., Serra, C., Carrato, A., Garc?′a-Closas, R., Sala, M., Lloreta, J., Tardon, A., Rothman, N. and Silverman, D.T. (2006) Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender. Cancer Epdemio Markers, 15, 1345-1354.
|
[6]
|
Van Hemelrijck M. J. J., Michaud, D.S., Connolly, G.N. and Kabir, Z. (2009) Tobacco use and bladder cancer patterns in three western European countries. Journal of Public Health, 31, 335-344. doi:10.1093/pubmed/fdp062
|
[7]
|
Raman, J.D., Messer, J., Sielatycki, J.A. and Hollenbeak, C.S. (2010) Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, British Journal of Urology International, 107, 1059-1064.
|
[8]
|
Alberg, A.J. and Hebert, J.R. (2009) Cigarette Smoking and Bladder Cancer: A New Twist in an Old Saga? Journal of the National Cancer Institute, 101, 1525-1526.
doi:10.1093/jnci/djp385
|
[9]
|
López, A.G., González, C.A., Errezola, M., Escolar, A., Izarzugaza, I., Nebot, M. and Riboli, E. (1991) Tobacco smoke inhalation pattern, tobacco type, and bladder cancer in Spain. American Journal of Epidemiology, 134, 830-839.
|
[10]
|
Hoffmann, D., Rivenson, A., Chung, F.L. and Wynder, E.L. (1993) Potential inhibitors of tobacco carcinogenesis. Annals of the New York Academy of Sciences, 28, 140-160. doi:10.1111/j.1749-6632.1993.tb39169.x
|
[11]
|
Arnaud, M.J. (1993) Metabolism of caffeine and other components of coffee. In: Garattini, S. Ed., Caffeine, Coffee and Health, Raven Press, New York.
|
[12]
|
B’chir, F., Laouani, A., Ksibi, S., Arnaud, M.J. and Saguem, S. (2007) Cigarette filter and the incidence of lung adenocarcinoma among Tunisian population. Lung cancer Amsterdam Netherlands, 57, 26-33.
doi:10.1016/j.lungcan.2007.01.034
|
[13]
|
Lilienfeld, A.M., Levin, M. and Moore, G.E. (1956) The association of smoking with cancer of the urinary bladder in humans. Archives of Internal Medicine, 98, 129-135.
|
[14]
|
U. S. Department of Health and Human Services. (2004) The Health Consequences of Smoking, A Report of the Surgeon General, Atlanta.
|
[15]
|
Gandini, S. et al. (2008) Tobacco smoking and cancer: A meta-analysis. International Journal of Cancer, 122, 5-64. doi:10.1002/ijc.23033
|
[16]
|
Gough, K.R., Read, A.E., McCarthy, C.F. and Waters, A.H. (1963) Megaloblastic anaemia due to nutritional deficiency of folic acid. QJM, 32, 243-256.
|
[17]
|
Chanarin, I., MacGibbon, B.M., O’Sullivan, W.J. and Mollin, D.L. (1959) Folic-acid deficiency in pregnancy. The pathogenesis of megaloblastic anaemia of pregnancy. Lancet, 2, 634-639. doi:10.1016/S0140-6736(59)91409-6
|
[18]
|
Pavanello, S., Mastrangelo, G., Placidi, D., Campagna, M., Pulliero, A., Carta, A., Arici, A. and Porru, S. (2010) CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer. European Journal of Epidemiology, 25, 491-500.
doi:10.1007/s10654-010-9479-8
|
[19]
|
Van der Boon J. (2001) Low-tar ?lter cigarettes and an aggressive type of lung cancer. Lancet Oncology, 2, 255.
doi:10.1016/S1470-2045(00)00310-7
|
[20]
|
Hoffmann, D., Rivenson, A., Murphy, S.E., Chung, F.L., Amin, S. and Hecht, S.S. (1993) Cigarette smoking and adenocarcinoma of the lung: The relevance of nicotine- derived N-nitrosamines. Journal of Smoking Related Disorder, 4, 165-189.
|
[21]
|
Wogan, G.N., Hecht, S.S., Felton, J.S., Conney, A.H. and Loeb, L.A. (2004) Environmental and chemical carcinogenesis. Seminars in Cancer Biology, 14, 473-486.
doi:10.1016/j.semcancer.2004.06.010
|
[22]
|
Morabia, A. and Wynder, E.L. (1991) Cigarette smoking and lung cancer cell types. Cancer, 68, 2074-2048.
doi:10.1002/1097-0142(19911101)68:9<2074::AID-CNCR2820680939>3.0.CO;2-X
|
[23]
|
Wald, N., Idle, M. and Smith, P.G. (1977) Carboxyhaemoglobin levels in smokers of filter and plain cigarettes. The Lancet, 1, 110-112.
doi:10.1016/S0140-6736(77)91702-0
|
[24]
|
Lubin, J.H., Alavanja, M.C.R., Caporaso, N., Brown, L.M., Brownson, R.C., Field, R.W., Garcia-Closas, M., Hartge, P., Hauptmann, M., Hayes, R.B., Kleinerman, R., Kogevinas M, Krewski D, Langholz B, Le tourneau E G, Lynch. C.F, Malats, N., Sandler, N.P., Schaffrath-Rosario, A., Schoenberg, J.B., Silverman, D.T., Wang, Z., Wichmann, H.E., Wilcox, H.B. and Zielinski, J.M. (2007) Cigarette smoking and cancer risk: Modeling total exposure and intensity. American Journal of Epidemiology, 166, 479-489.
|
[25]
|
Hoffmann, D., Brunnemann, K.D., Prokopczyk, B. and Djordjevic, M.V. (1994) Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: Chemistry, biochemistry, carcinogenicity and relevance to humans. Journal of Toxicology and Environmental Health, 41, 1-52.
doi:10.1080/15287399409531825
|
[26]
|
Hecht, S.S., Isaacs, S. and Trushin, N. (1994) Lung tumor induction in A/J mice by the tobacco smoke carcingens4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone and benzo (a) pyrene: A potentially useful model for evaluation of chemopreventive agents. Carcinogenesis, 15, 2721-2725. doi:10.1093/carcin/15.12.2721
|
[27]
|
Balansky, R., Ganchev, G., ltcheva, M., Steele, V.E., D’ Agostini1, F. and De Flora S. (2007) Potent carcinogenicity of cigarette smoke in mice exposed early in life. Carcinogenesis, 28, 2236-2243.
doi:10.1093/carcin/bgm122
|
[28]
|
Landi, M.T., Sinha, R., Lang, N.P. and Kadlubar, F.F. (1999) Human cytochrome P4501A2. In: Vineis, P., Malats, N., Lang, M., d’Errico, A., Caporaso, N., Cuzick, J. and Moffetta, P., Eds., Metabolic polymorphisms and susceptibility to cancer. IARC Scientific Publications, Lyon, 173-195.
|
[29]
|
Vineis, P., Talaska, G., Malaveille, C., Bartsch, H., Martone, T., Sithisarankul, P. and Strickland, P. (1996) DNA adducts in urothelial cells: Relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. International Journal of Cancer, 65, 314-316.
doi:10.1002/(SICI)1097-0215(19960126)65:3<314::AID-IJC6>3.0.CO;2-2
|
[30]
|
Bonser, G.M., Bradshaw, L., Clayson, D.B. and Jull, J.W. (1956) A further study of the carcinogenic properties of ortho hydroxy-amines and related compounds by bladder implantation in the mouse. British Journal of Cancer, 10, 539-546. doi:10.1038/bjc.1956.63
|
[31]
|
Lee, S.W., Jang, I.J., Shin, S.G., Lee, K.H., Yim, D.S., Kim, S.W., Oh, S.J. and Lee, S.H. (1994) CYP1A2 activity as a risk factor for bladder cancer. Journal of Korean Medical Science, 9, 482-489.
|
[32]
|
Guengerich, F.P. and Shimada, T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391-407. doi:10.1021/tx00022a001
|
[33]
|
Kamataki, T., Fujita, K., Nakayama, K., Yamazaki, Y., Miyamoto, M. and Ariyoshi, N. (2002) Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: Application of genetically engineered Salmonella expressing human CYP. Drug Metabolism Reviews, 34, 667-676.
doi:10.1081/DMR-120005668
|
[34]
|
Landi, M.T., Zocchetti, C., Bernucci, M., Kadlubar, F.F., Tannenbaum, S., Skipper, P., Bartsch, H., Malaveille, C., shields, P., Caporaso, N. and Vinei, P. (1996) CytochromeP4501A2: Enzyme Induction and Genetic Control, Determining 4-aminobiphenyl-hemoglobin Adduct Levels. Cancer Epidemiology, Biomarkers & Prevention, 5, 693-698.
|
[35]
|
Le Marchand, L., Hankin, J.H., Wilkens, L.R., Pierce, L.M., Franke, A., Kolonel, L.N., Seifried, A., Custer, L.J., Chang, W., Lum, J.A. and Donlon, T. (2001) Combined Effects of Well-done Red Meat, Smoking, and Rapid N-Acetyltransferase 2 and CYP1A2 Phenotypes in Increasing Colorectal Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention, 10, 1259-1266.
|
[36]
|
Working group on the Evaluation of Carcinogenic Risks to Humans. (2004) Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Lyon, 1-1438.
|